Xencor
XNCR
33.26
-0.75
-2.21%
Xencor
US · XNCR
#2825 by market cap
Listed 1970
33.26
-0.75
-2.21%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:51
About Xencor
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Pasadena, CA.
- Founded
- 1997
- CEO
- Dr. Bassil I. Dahiyat, PhD.
- Employees
- 260
- Headquarters
- Pasadena, California, United States of America
- Fiscal year end
- 12-31
- Website
- xencor.com
Company profile
- Exchange
- US
- Symbol
- XNCR
- Market-cap rank
- #2825
- Listing date
- 1970-01-01
- Market cap
- 2.50B
- Float cap
- 1.86B
- Shares out
- 75.04M
- Float shares
- 55.81M
Sectors & themes
Biotechnology
Global medical industry
Fractional Shares JP
Quote time 2026-11-20 19:51:50 · For reference only, not investment advice and not tailored to your situation.
Xencor discussion 0 comments